首页> 外国专利> FLAVANONE DERIVATIVES AND COMPOSITION FOR PREVENTING OR TREATING BLOOD LIPID LEVEL-RELATED DISEASES COMPRISING SAME

FLAVANONE DERIVATIVES AND COMPOSITION FOR PREVENTING OR TREATING BLOOD LIPID LEVEL-RELATED DISEASES COMPRISING SAME

机译:黄酮衍生物和成分的预防或治疗血脂水平相关的疾病

摘要

A compound of formula (I) treating or preventing an elevated blood lipid level-related disease and inhibiting the activities of acyl-CoA:cholesterol-O-acyltransferase(ACAT) and 3-hydroxy-3-methylglutaryl CoA(HMG-CoA) reductase:wherein,R1 is R5 R6CO group;R2 is H or R6CO group;R3 is H, CH3, R5 or R6CO group;R4 is H, OH, OR5 or R6COO group;R5 is a C2-5 alkyl group substituted with a phenyl group optionally having one or more substituents selected from the group consisting of C1-3 alkyl, OH, Cl and NO2; a C1-5 alkyl group substituted with a naphthyl group optionally having one or more substituents selected from the group consisting of C1-3 alkyl, OH, Cl and NO2; a C10-18 alkyl; or a C10-18 alkenyl group; andR6 is a C10-18 alkenyl group; or an aryl group optionally having one or more substituents selected from the group consisting of C1-3 alkyl, OH, Cl or NO2.
机译:式(I)的化合物,其治疗或预防与血脂水平升高相关的疾病并抑制酰基-CoA:胆固醇-O-酰基转移酶(ACAT)和3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶的活性:其中,R1为R5,R6CO基; R2为H或R6CO基; R3为H,CH3,R5或R6CO基; R4为H,OH,OR5或R6COO基; R5为被苯基取代的C2-5烷基任选具有一个或多个选自C 1-3烷基,OH,Cl和NO 2的取代基的基团; [0127]被萘基取代的C 1-5烷基,所述萘基任选具有一个或多个选自C 1-3烷基,OH,Cl和NO 2的取代基; C10-18烷基;或C 10-18烯基;或R6为碳数10〜18的链烯基。或任选具有一个或多个选自C 1-3烷基,OH,Cl或NO 2的取代基的芳基。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号